Wang, Yalong
Fang, Lingling
Hu, Xiao
Wu, Hongliang
Zhou, Lina
Xue, Qi
Gao, Shugeng
He, Jie
Funding for this research was provided by:
Beijing Hope Run Special Fund of Cancer Foundation of China (LC2022B19)
Natural Science Foundation of Beijing Municipality (7224342)
National Anti-Tumor Drug Surveillance System of National Cancer Center (DSS-YSF-2023022)
Article History
Received: 30 July 2023
Accepted: 19 March 2024
First Online: 10 April 2024
Declarations
:
: The authors declare no competing interests.